The latest investment in the Lebanon site comes after an announcement in May of $5.3 billion earmarked to build production capacity for Lilly’s obesity and diabetes drugs. All told, the company said ...
FIRST RESPONDERS ON THE SEACOAST HAVE RELIED ON EXETER, ALS, THEIR PARAMEDICS OFFER A MORE ADVANCED CARE THAN MANY ... HOSPITAL TO COME UP WITH A PROPER PLAN TO FILL THIS VOID.